Nephros Inc (NEPH)
NASDAQ:NEPH
Want to see NEPH full AI Analyst Report?
NEPH Stock Chart & Stats
$5.01
<$0.01(0.48%)
At close: 4:00 PM EST
$5.01
<$0.01(0.48%)
Day’s Range― - ―
52-Week Range$2.28 - $6.42
Previous Close$1.57
Volume70.00
Average Volume (3M)75.62K
Market Cap
$37.67M
Enterprise Value$34.62M
Total Cash (Recent Filing)$4.02M
Total Debt (Recent Filing)$968.00K
Price to Earnings (P/E)56.7
Beta-0.37
Next Earnings
Aug 12, 2026Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding10,856,546
10 Day Avg. Volume107,933
30 Day Avg. Volume75,620
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)5.08
Price to Sales (P/S)2.76
P/FCF Ratio31.48
Enterprise Value/Market Cap0.92
Enterprise Value/Revenue1.81
Enterprise Value/Gross Profit3.07
Enterprise Value/Ebitda42.53
Forecast
1Y Price Target
$8.00Price Target Upside59.68% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.06
Revenue Forecast (FY)$20.60M
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetLow leverage and an equity base that has grown over time provide durable financial flexibility. Being essentially debt-light reduces refinancing and interest risks, supporting continued investments in installations, services, and geographic expansion during multi-quarter scale-up efforts.
Recurring Installed-base GrowthStrong programmatic growth and an expanding installed base create predictable recurring revenue from replacements and services. That installed-base-driven consumable demand supports durable revenue visibility, improves lifetime customer value, and underpins margin recovery as scale and reorders rise.
Addressable Market & Services ExpansionMoving into larger commercial end-markets while building services and education diversifies TAM and reduces dependence on episodic emergency sales. Service-led adoption and training increase customer retention and recurring revenue potential, supporting more stable long-term unit economics.
Bears Say
Weak Cash GenerationA reversal to negative operating and free cash flow raises sustainability concerns: continued cash burn can force trade-offs between working-capital needs, inventory refresh, and investment in growth initiatives. This constrains capital flexibility over several quarters if cash conversion doesn't improve.
Gross Margin CompressionAn 8ppt gross margin drop driven by tariffs, FX and lower-margin product mix undermines durable profitability. If tariff/FX impacts or a structural shift toward lower-margin commercial products persist, margin recovery will depend on cost mitigation and product mix management over multiple quarters.
Rising Operating Expenses & Profit DeclineMaterial profit and EBITDA declines alongside rising R&D and SG&A reflect weaker earnings leverage. Sustained higher operating expense levels for expansion efforts can prolong cash burn and compress returns unless top-line growth and margin mix improvements outpace expense growth over the medium term.
Nephros News
NEPH FAQ
What was Nephros Inc’s price range in the past 12 months?
Nephros Inc lowest stock price was $2.28 and its highest was $6.42 in the past 12 months.
What is Nephros Inc’s market cap?
Nephros Inc’s market cap is $37.67M.
When is Nephros Inc’s upcoming earnings report date?
Nephros Inc’s upcoming earnings report date is Aug 12, 2026 which is in 77 days.
How were Nephros Inc’s earnings last quarter?
Nephros Inc released its earnings results on May 07, 2026. The company reported $0.01 earnings per share for the quarter, the consensus estimate of $0.01 by $0.
Is Nephros Inc overvalued?
According to Wall Street analysts Nephros Inc’s price is currently Undervalued.
Does Nephros Inc pay dividends?
Nephros Inc does not currently pay dividends.
What is Nephros Inc’s EPS estimate?
Nephros Inc’s EPS estimate is 0.
How many shares outstanding does Nephros Inc have?
Nephros Inc has 10,856,546 shares outstanding.
What happened to Nephros Inc’s price movement after its last earnings report?
Nephros Inc reported an EPS of $0.01 in its last earnings report, expectations of $0.01. Following the earnings report the stock price went up 8.978%.
Which hedge fund is a major shareholder of Nephros Inc?
Currently, no hedge funds are holding shares in NEPH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nephros Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.00 (59.68% Upside)
$8.00 (59.68% Upside)
Hedge Fund Trend
Decreased
By 11.5K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
226.00%
12-Months-Change
Fundamentals
Return on Equity
7.66%
Trailing 12-Months
Asset Growth
17.12%
Trailing 12-Months
Company Description
Nephros Inc
Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells real-time water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it offers water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and AETHER brands for the food service, hospitality, convenience store, and health care markets. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
NEPH Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a mixed but constructive picture: Nephros achieved a record revenue quarter and strong programmatic growth while expanding customer footprint, services and addressable markets. However, profitability and margins were materially compressed this quarter (gross margin down 8 points, net income down 75%, adjusted EBITDA down 69%) due to tariffs, currency headwinds and a deliberate shift into lower-margin commercial applications. Management is pursuing tariff refunds, has reduced tariff rates (15% to 10%) and expects margins to improve as new inventory cycles through and mitigation actions take effect. Given the balance of a clear revenue and strategic growth story against significant near-term margin and profit pressure, the overall tone is cautiously optimistic but tempered by the notable financial headwinds.View all NEPH earnings summariesNEPH Stock 12 Month Forecast
Average Price Target
$8.00
▲(59.68% Upside)
Technical Analysis
Ownership Overview
4.77% Insiders
2.36% Mutual Funds
43.04% Other Institutional Investors
47.93% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---